Oncology Experts Panel

In this conversation moderated by Vera Mucaj, Head of Trials and Chief Scientist at Datavant, our panelists shared how they're thinking about current trends and future needs in oncology and RWD, including the following topics:

- Using RWD endpoints in oncology clinical development and beyond
- Considerations around the use of novel data sources (e.g., genomic data)
- The role of RWD in step-change innovation across the oncology clinical development and commercial lifecycle (e.g., seamless trials, increased diversity in recruitment, improving patient access)